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Introduction
Parkinson’s disease (PD) is a chronic disorder spread 
worldwide. Around 7 million people in the world live with 
PD1. Traditionally the disease has been a condition associ-
ated with ageing and the elderly. However, it is not un-
usual with individuals who experience the onset of the 
disease already in their thirties and forties. PD is a brain 
disorder with severe and incapacitating somatic symp-
toms: tremor, rigid muscles, slowness, and impaired pos-
ture and balance. Also non-somatic symptoms such as 
depression and dementia are associated with the disorder. 
Besides this, Parkinson’s disease is a highly degenerative 
or progressive condition. The first symptoms experienced 
by an individual may be quite mild, a trembling finger for 
example. But the disease gets worse and may eventually 
become a stigmatizing disability for the individual. The 
end stage of Parkinson’s disease is feared by many. It can 
involve the inability to stand and walk as well as to take 
care of oneself.
There is no cure for Parkinson’s disease, even though 
the disorder has been known for centuries. The first time 
it was described in a more systematic way was by the Brit-
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ish doctor James Parkinson. This was in the beginning of 
the 19th century and the disease was at the time called 
‘shaking palsy’. The disease received its current name – 
Parkinson’s disease – in the second half of the 19th cen-
tury when the renowned French physician Jean-Martin 
Charcot proposed the new name1. It is still not known 
what exactly causes the onset of the disease. However, in 
the mid-20th century it was discovered that PD is linked 
to the loss of dopamine-producing cells in the brain. This 
scientific discovery led to the development of the drug le-
vodopa as an effective medication for the PD symptoms. 
Nonetheless, it has turned out that after some years of 
medication, levodopa has serious side-effects for the pa-
tient. These side-effects, such as involuntary movements 
of the body (dyskinesias), can be as bad and painful for the 
individual as the disorder itself.
Material and Methods
Today, there is active biomedical research on PD in 
many parts of the world and within many fields of re-
search. One of these research fields concerns the trans-
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plantation of dopamine-producing neuron cells and stem 
cells into the brain of the invalid patient. This field has 
expanded a great deal over some decades, ever since the 
first clinical trials were conducted in the second half of the 
1980s2. In present time, a number of different neuroscien-
tific centers in Europe collaborate in order to realize new 
clinical trials with dopamine-producing cells, under the 
EU-funded programme TRANSEURO. This programme 
started in 2010 and, after several years of modifying the 
technology and selecting patients for the trials, a small 
number of transplantations have now been conducted with 
patients in different European countries.
In my own work as ethnologist, I have followed the ex-
pansion of this biomedical programme for some years. I 
have conducted observations in different settings and focus 
groups and held individual interviews with clinical scien-
tists, medical staff, patients, family members and the pub-
lic, in order to learn more about what characterizes clinical 
research in a context where scientists and patients interact 
2,3. What kind of collaborations can be identified between 
different actors and interests? My aim is to explore the 
possibilities for a mutual partnership between patients and 
researchers and thereby establish a new conceptual space 
for how the two categories relate to each other.
Biomedical research is normally quite a hierarchical 
practice with only the researchers themselves as active 
agents, while patients, families and the public have often 
been seen more as objects or instruments for conducting 
science in different ways. However, in the last few years 
there have been an increasing number of studies within 
social sciences and the humanities, which in different 
ways challenge the dominance of the natural sciences by 
introducing a more participatory, inclusive as well as 
critical perspective on the issues4,5. My own research is a 
part in this scholarly development.
Below, I will draw attention to two concepts which, in 
different ways, can sharpen an analysis of the type of par-
ticipatory network that may be represented in clinical sci-
ence. First, it is the spatial concept of concordance which 
highlights the relationship between research patients and 
clinical scientists as a possible partnership. Second, I will 
focus upon the concept of synchronizing, which refers to 
how affected individuals move along tactically in relation 
to how science, in parallel, moves into new stages and 
generates new expectations.
Discussion
Concordance, my first term here, has its conceptual 
background in a health care discourse around year 2000. 
In a recent review, the medical sociologist David Arm-
strong identifies the birth of the concept as a development 
of and movement away from the long-term, and often non-
productive, discussion on whether patients comply or not 
in different clinical situations. When the term concor-
dance was introduced this implied, Armstrong writes, ‘a 
greater agreement between doctor and patient on the na-
ture of the problem, the need for treatment and the most 
appropriate medication’6. Armstrong continues: ‘Default 
and non-compliance had indicated a failure of the patient; 
lack of concordance reflected [in contrast] a failure of the 
consultation, mostly through the physician not having 
elicited the true nature of the patient’s problem […] or the 
patient’s real concerns’6. Concordance, in Armstrong’s 
view, was thus meant to endorse »a form of open consulta-
tion that encouraged the patient[s] to express their true 
selves by verbalizing their inner life-worlds«6. Not all 
scholars have been as positive towards the concept as 
Armstrong appears to be in his article. Judy Z. Segal, with 
an interest in the history and theory of rhetoric, is for 
example more critical of the concept of concordance. In an 
article from 2007, she sees the concept as »a sham« and as 
»a strategy for compliance«7. Patients may be addressed 
as »partners«, but in reality this is, according to Segal, 
just another way of bringing the patients »into agreement 
with physicians’ prescriptions«7.
Still, I adhere to the concept as I see two important 
cultural analytic aspects of concordance. First, the con-
cept of concordance promotes, as Armstrong articulates, 
a new openness for how doctors and patients relate to each 
other. We could say that there is a new space for cultural 
creativity in a relationship which historically has been 
rather fixed and conformist. Second, the concept of concor-
dance, if we follow Armstrong, also relates to a patient-
centering perspective which de-centers the authority of 
the doctor (read: the clinical scientist)6. I believe this pa-
tient-empowering aspect of concordance is the most im-
perative of all.
The patient-centering of concordant space can in this 
respect be linked to a radical time perspective on how the 
patients relate to their encounter with the doctors and the 
researchers. On the basis of this time orientation, my sec-
ond term will be synchronizing. This concept is my own 
invention and it stems from my reading of the sociologist 
Kathy Charmaz’s book »Good Days, Bad Days: The Self 
in Chronic Illness and Time«, from 1991. Here she points 
at how individuals with different kinds of chronic diseas-
es live their lives in a very time structured and time reflec-
tive way. She discusses how time experience is fundamen-
tal for how the chronically ill constitute their selves and 
how they organize and cope with their lives8.
This radical time perspective of the individual patients 
is a way for me to achieve patient-centering in my study 
on what research patients experience in clinical trials. It 
is a means for understanding how a certain form of agree-
ment may arise in the relationship between patients and 
clinical scientists even though the experiences and inter-
ests of the two categories may vary greatly. Through look-
ing at concord rather than conflict, I highlight how indi-
viduals time the tempo of their own embodied progression 
into the disease with the opportunity to take part in clin-
ical trials. Individuals in this respect negotiate their own 
progress into the complex condition of the illness with how 
they experience the movement of science, whether it is 
experienced as slow or fast, certain or uncertain, et cetera. 
In my fieldwork I have encountered two discrete modes of 
synchronizing in relation to clinical trials in general, and 
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the cell transplant trials in particular: aligning and nav-
igating.
Aligning means that one actively makes one’s life par-
allel with the scientific trials. Annika, a key interview 
subject in my study, was in her early forties when she 
contracted PD. Initially, she was in a state of shock and 
alienation. She started to look for information about the 
disease on the internet, but felt depressed. She could not 
identify with the disease and other people with PD who, 
in her eyes, were all elderly. But after some time, she came 
in contact with individuals of her own age and who also 
suffered from the disease. She decided to become more 
active in the patients’ organization. At that time, she went 
to a lecture about a forthcoming research project on cell 
transplantation. After the lecture, she confronted the 
speaker/researcher and asked if she could take part in the 
future trials. She saw this as a chance to test something 
different. She was aware that the specific cell material 
and the specific method to be used may not prove suitable 
for everyone. Still, she wanted to test this possibility be-
fore she had come too far in the progression of the disease.
Since then, more than five years have passed. Annika 
has taken part in the biomedical research project. First, 
she was in a large observation group with different pa-
tients. Then, she became part of a smaller group, where 
she underwent different kinds of tests. Her condition was 
measured and evaluated in various ways. Eventually, she 
was one of the individuals who were randomized into the 
transplant group. At the time of writing, she has recently 
been transplanted with experimental cells into her brain 
and will now be subjected to medical follow-up for a 
number of years.
In Annika’s case, aligning is thus a form of synchroniz-
ing movement where accepting the conditions is central 
for how one times one’s own life and self with the institu-
tionalizing practices of science. Her example shows how 
aligning is a movement on several levels. It is a chrono-
logical movement. She feels that she has reached an age 
and knows that there will be not so many more opportuni-
ties. It is an embodied movement. She has progressed into 
the disease this far and feels that she cannot progress any 
more now before it is too late. And it is an imagination of 
how the significant Other – the scientists – moves. She 
believes that research is making progress right now and 
feels that she needs to keep up-to-date with this.
Navigating, the other form of synchronizing that I 
want to pinpoint, is in contrast to aligning a movement 
where one sometimes turns away from clinical science, but 
just momentarily or for a period of time. It is not rejecting 
science, for a turning down can be followed by aligning, 
depending on the movements of life (and science). Navigat-
ing is more about living with one’s disease in transit, in 
relation to the movements of science. This synchronizing 
movement includes dis-matching from science, but also 
essential moments of matching oneself with these prac-
tices. In this case Magnus’ story can be illustrative. Like 
Annika, he contracted PD in his early forties. To start 
with, he turned down a request from one of the nurses at 
the clinic. It was not a formal request. The nurse only 
checked whether he had any interest in participating in 
clinical trials at all. However, he became more and more 
interested in the scientific alternative and after a popular 
lecture by a scientist on cell transplant research he, pret-
ty much like Annika, confronted the lecturer afterwards 
and asked if there was any possibility of joining as a trans-
plant participant. He gave the researcher his name, and 
after some time he was enrolled in the project. When a 
friend, who also has Parkinson, questioned his decision by 
asking how he could let them »juggle with your brain«, he 
concluded that this friend was ten years younger than 
himself. Magnus saw this trial participation as »my 
chance to get something which I believe in«.
However, his participation in the research project has 
not really corresponded to his expectations. Like Annika, 
he has undergone several tests over the years, but, unlike 
her, he was randomized into the control group whose mem-
bers are not going to receive a transplant. This was a great 
disappointment for him, and consequently he deliberated 
on whether to withdraw from the project, something he 
was free to do according to the informed consent sheet he 
had signed at the start. Still, he decided to stay in the 
study since he realized that it was going to be difficult to 
replace him, and since he also was promised to take part 
in the new trials that were already planned after the 
present project was finished.
Navigating is similar to the cultural theorist Michel de 
Certeau’s concept of tactic mobility. As a synchronizing 
movement, navigating takes the individual across that 
sort of, in de Certeau’s words, »enemy territory« that sci-
ence may represent for potential research patients9. Quite 
often, it is not an alternative for a sick individual to take 
part in clinical trials. But occasionally, it happens that one 
becomes interested in the possibility of making one’s life 
parallel with the movement of science. In this instance, 
the sick individual may cross new boundaries and try con-
tacting scientists in different ways.
Conclusion
Concordance and synchronizing – together these terms 
work for a different view on the almost archetypical rela-
tionships of doctors and patients on the one hand, and of 
scientists and lay people on the other – a new type of view 
where the »weaker« part of the involved protagonists is 
given more space and possible impact than before9. Patient 
expertise and lay knowledge are, from this viewpoint, two 
sides of the same coin, ethically and politically. However, 
in both cases there is bewilderment about, and even a 
resistance against, how far one can go in the very argu-
ment. Even though patients may be seen as experts on 
their own bodies, usually it is the doctor, not the patient, 
who is active and has special responsibility for the nature 
of the medical problems. And even though lay individuals 
may make important contributions to science, usually it 
is the scientist, not the lay individual, who performs the 
final analyzes and comes to the final conclusions. There-
fore the figure of the participating research patient can be 
experienced as a challenge in many different respects.
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KONKORDANTAN PROSTOR BIOMEDICINSKE ZNANOSTI: KAKO SE OSOBE S PARKINSONOVOM 
BOLEŠĆU USKLAĐUJU SA KLINIČKIM ISTRAŽIVANJIMA
S A Ž E T A K
Parkinsonova bolest postaje sve je učestalija starenjem zapadnjačkih populacija. Postoji lijek Levodopa, ali je povezan 
s nuspojavama. U potrazi za alternativnom terapijom pacijenti djeluju na različite načine. Njihovo sudjelovanje u 
kliničkim istraživanjima nerijetko otvara mogućnost laičkog utjecaja na znanost. U ovome radu postavlja se pitanje kako 
se netko kao pacijent odnosi prema kliničkoj znanosti. Kako netko postupno prihvaća ono što, na temelju svoje degenera-
tivne bolesti, shvaća kao napredak znanosti? Osobe oboljele od Parkinsonove bolesti su u tom smislu vremenski ograničena 
bića u svemu što čine ili kalkuliraju u vezi znanosti. Na temelju etnografskog istraživanja provedenog u okviru biomedi-
cinskog znanstvenog projekta o transplantaciji stanica, u radu se preispituju dva različita pojma,  konkordancija i sink-
ronizacija, s obzirom na njihov analitički potencijal za razumijevanje načina na koji pacijenti sudjeluju u kliničkim 
istraživanjima.
